Subscribe

SEARCH RESULT

Thursday, November 27, 2025
Boehringer Ingelheim gets positive opinions from European Medicines Agency for marketing of bird flu vaccines
Boehringer Ingelheim, a global leader in preventive medicines for livestock, obtained positive opinions by the European Medicines Agency (EMA) recommending the granting of marketing authorisations under exceptional circumstances for its avi ...
Wednesday, October 15, 2025
Boehringer Ingelheim Cares Foundation launches comprehensive animal health programme to support veterinarians and increase access to veterinary care
Boehringer Ingelheim has launched a US$2.5 million comprehensive Boehringer Ingelheim Cares Foundation Animal Health Programme.
Friday, June 20, 2025
Boehringer Ingelheim introduces advanced three-in-one poultry vaccine in India
Boehringer Ingelheim, a global leader in animal health, has launched its latest three-in-one poultry vaccine in India.
Friday, May 9, 2025
Boehringer Ingelheim gets approval for use of bluetongue vaccines in UK and Ireland
Boehringer Ingelheim has welcomed new regulatory approvals for use of its bluetongue vaccine in the United Kingdom and Ireland.
Thursday, February 27, 2025
Boehringer Ingelheim launches new trivalent poultry vaccine
With VAXXITEK® HVT+IBD+H5, Boehringer Ingelheim is expanding its proven VAXXITEK® range with a new vaccine that protects against three severe poultry diseases: Marek's disease, Infectious Bursal Disease, and H5 avian influenza.
Monday, July 22, 2024
Boehringer Ingelheim unveils PCV2 Decision Tree for improved swine disease management
Boehringer Ingelheim has launched the PCV2 Decision Tree to aid producers and veterinarians in making informed decisions regarding porcine circovirus associated disease (PCVAD) management strategies, Farm Journal's Pork reported.
Tuesday, September 20, 2022
Boehringer Ingelheim launches Fencovis vaccine to prevent calf diarrhea
Boehringer Ingelheim is adding a new vaccine to its bovine vaccine portfolio with the launch of Fencovis® for the prevention of calf diarrhea and providing passive immunity to calves through the cows' maternal colostrum.
Tuesday, March 15, 2022
New swine vaccine by Boehringer Ingelheim to combat reproductive diseases
Boehringer Ingelheim has introduced a new swine vaccine to help producers fight against reproductive diseases.
Tuesday, March 1, 2022
Boehringer Ingelheim calls for proposals for expanded swine-related research
Boehringer Ingelheim is calling for proposals for its newly-expanded research funding programme, Growing Research and New Technology for Swine.
Tuesday, November 16, 2021
Boehringer Ingelheim announces new appointments in swine, poultry divisions
Boehringer Ingelheim Animal Health recently announced two new appointments to its US swine and poultry divisions.
Monday, August 30, 2021
Boehringer Ingelheim to continue supply to US FMD vaccine bank
The United States Department of Agriculture has selected Boehringer Ingelheim to continue supplying antigen for a vaccine bank that protects US livestock from a potential outbreak of foot-and-mouth disease (FMD).
Tuesday, July 13, 2021
Boehringer Ingelheim's smartphone app brings pig vaccination to next level
Boehringer Ingelheim has announced that its FreVAX™ intramuscular needle-free device can now be managed via the new version of the FreVAX™ smartphone app.
Monday, July 5, 2021
Boehringer Ingelheim celebrates 25 years combating PRRS in Europe
Boehringer Ingelheim was celebrating 25 years of partnering with veterinarians and producers to combat porcine reproductive and respiratory syndrome (PRRS) in Europe and more than 25 years in the United States, the company announced last mo ...
Friday, June 11, 2021
Boehringer Ingelheim to prioritise R&D using AI
Boehringer Ingelheim announced earlier this week the beginning of a long-term partnership with Lifebit Biotech to utilise deep learning, natural language processing and artificial intelligence (AI) for the detection and early-reporting of g ...
Tuesday, April 13, 2021
Boehringer Ingelheim introduces new-generation Marek's disease vaccine in EU and UK
Boehringer Ingelheim announced that it has introduced PREVEXXION® RN in the European Union and the United Kingdom. It is the first innovation in the Marek category of vaccines in over 40 years.
Video >
Most popular

Follow Us

FacebookTwitterLinkedIn
About Us
Company Profile
Our Team
Our Products & Services
Subscription
eNewsletter
Inquiry
Contact Us
Advertise With Us
Partner With Us
We use cookies to understand how you use our website and to improve your browsing experience.
This includes personalizing content and advertising. By continuing to use our website, you accept our use of cookies, updated Privacy Statement and Terms of Use.
Copyright ©2001 - 2026 eFeedLink. All rights reserved.